Clinical trial
A Prospective, Randomized, Double Blind, Controlled Trial to Evaluate Efficacy and Security of Intrapleurally Alteplase vs Urokinase for the Treatment of Complicated Parapneumonic Effusion and Pleural Empyema
NCT01246453 is registered in ClinicalTrials.gov with Hospital Universitari Vall d'Hebron Research Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Randomized, Double Blind, Controlled Trial to Evaluate Efficacy and Security of Intrapleurally Alteplase vs Urokinase for the Treatment of Complicated Parapneumonic Effusion and Pleural Empyema
- Lead sponsor
- Hospital Universitari Vall d'Hebron Research Institute
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- December 31, 2003
- Completion date
- December 31, 2010
- Enrollment
- 204 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.